Akèy › Kansè poumon › Texas

Etid klinik pou Kansè poumon nan Texas

101 etid pou Kansè poumon ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Hendrick Medical Center, Abilene
Houston Methodist San Jacinto Hospital, Baytown
Parkland Memorial Hospital, Dallas
ak 6 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

New Experimental Therapeutics - NEXT Oncology, Austin
Texas Oncology, Bedford
UT Southwest Simmons Cancer Center, Dallas
ak 2 plis

Ap rekriteFaz 1/2

Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

Texas Oncology - DFW ( Site 8003), Dallas

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06780098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

The Don and Sybil Harrington Cancer Center, Amarillo
UT MD Anderson Cancer Center, Houston
Audie L Murphy VA Hospital, San Antonio

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Parkland Memorial Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern Clinical Center at Richardson/Plano, Richardson

Ap rekriteFaz 3

Laj 70 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Houston Methodist San Jacinto Hospital, Baytown
Houston Methodist Cypress Hospital, Cypress
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
ak 6 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

SCRI at Mary Crowley, Dallas
University of Texas Southwestern Medical Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston
ak 1 plis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06625775

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Texas Oncology - South Austin, Austin
Texas Oncology Dallas, Dallas
MD Anderson Cancer Center, Houston
ak 1 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Houston
PHN-012-001 Site, San Antonio

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology - Northeast Texas, Allen
Texas Oncology - West Texas, Amarillo
ak 52 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Oncology Consultants PA, Houston
University of Texas MD Anderson Cancer Center, Houston
US Oncology Research Investigational Products Center, Irving

Ap rekriteFaz 3

Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT05920356

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe
Renovatio Clinical - El Paso, El Paso
The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
ak 10 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

University of Texas Medical Branch, Galveston
The University of Texas MD Anderson Cancer Center, Houston
Baylor Scott & White Health, Temple

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07154290

A Registry for People With Lung Cancer

Baylor University Medical Center (Data Collection Only), Dallas
MD Anderson Cancer Center (Data Collection Only), Houston

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06424327

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NEXT Oncology - Irving, Irving

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06618287

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0433, Dallas
University of Texas MD Anderson Cancer Center, Houston

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Houston

Ap rekriteFaz 2

Laj 18 a 95 · Tout sèks · Mizajou Sep 23, 2026 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

MD Anderson, Houston
NEXT Dallas, Irving
NEXT Oncology San Antonio, San Antonio
ak 1 plis

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Local Institution - 0025, Houston
Local Institution - 0173, San Antonio

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07100080

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M D Anderson Cancer Center, Houston

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04038619

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NEXT - Dallas, Dallas
NEXT, San Antonio
START - San Antonio, San Antonio

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

MD Anderson Cancer Center, Houston
START San Antonio, San Antonio

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

M D Anderson Cancer Center, Houston

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05010109

The Rise in Robotic Atypical Segmentectomies

M D Anderson Cancer Center, Houston

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Sep 14, 2026 · NCT04644952

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Start - Dfw, Fort Worth
Oncology Consultants, Houston
START - San Antonio, San Antonio

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

The University of Texas Southwestern Medical Center at Dallas, Dallas
Renovatio Clinical - El Paso, El Paso
JPS Health Network, Fort Worth
ak 5 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Texas Oncology, Austin
William Beaumont Army Medical Center, Fort Bliss
Houston Methodist Hospital, Houston
ak 3 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

MD Anderson Cancer Center, Houston

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06561685

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The University of Texas - MD Anderson Cancer Center, Houston

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06400472

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Dallas
Avenzo Therapeutics Recruiting Site, Houston
Avenzo Therapeutics Recruiting Site, San Antonio

Ap rekriteFaz 1/2

Laj 18 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Oncology Consultants Texas Medical Center, Houston
USOR - Texas Oncology - (DFW) Waco, Waco

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06343402

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

M D Anderson Cancer Center, Houston

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT04892953

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Texas Oncology, Dallas
The University of Texas MD Anderson Cancer Center, Houston

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

The University of Texas MD Anderson Cancer Center, Houston
Texas Oncology Cancer Center, Sugar Land

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06712355

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

START San Antonio, San Antonio

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017

Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity

The University of Texas M. D. Anderson Cancer Center, Houston

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06909201

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

University of Texas, MD Anderson Cancer Center, Houston

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

MD Anderson in The Woodlands, Conroe
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Ben Taub General Hospital, Houston
ak 4 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05624996

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.